Biovica International AB (OSTO:BIOVIC B) FCF Margin % : -2,117.21% (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biovica International AB's Free Cash Flow for the three months ended in Jan. 2024 was kr-22.76 Mil. Biovica International AB's Revenue for the three months ended in Jan. 2024 was kr1.08 Mil. Therefore, Biovica International AB's FCF Margin % for the quarter that ended in Jan. 2024 was -2,117.21%.

As of today, Biovica International AB's current FCF Yield % is -82.16%.

The historical rank and industry rank for Biovica International AB's FCF Margin % or its related term are showing as below:

OSTO:BIOVIC B' s FCF Margin % Range Over the Past 10 Years
Min: -2878.81 Med: -1828.07 Max: -589.19
Current: -1883.31

During the past 9 years, the highest FCF Margin % of Biovica International AB was -589.19%. The lowest was -2878.81%. And the median was -1828.07%.

OSTO:BIOVIC B's FCF Margin % is ranked worse than
81.05% of 1045 companies
in the Biotechnology industry
Industry Median: -143.92 vs OSTO:BIOVIC B: -1883.31

Biovica International AB FCF Margin % Historical Data

The historical data trend for Biovica International AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB FCF Margin % Chart

Biovica International AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

FCF Margin %

Get a 7-Day Free Trial

-841.80

-1,903.95

-1,828.07

-2,715.11

-2,878.81

Biovica International AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
FCF Margin %	Get a 7-Day Free Trial															-2,617.17	-3,167.33	-2,179.42	-1,105.62	-2,117.21

Competitive Comparison of Biovica International AB's FCF Margin %

For the Biotechnology subindustry, Biovica International AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biovica International AB's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biovica International AB's FCF Margin % falls into.

Biovica International AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biovica International AB's FCF Margin for the fiscal year that ended in Apr. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Apr. 2023 )	/	Revenue (A: Apr. 2023 )
	=	-97.419	/	3.384
	=	-2,878.81 %

Biovica International AB's FCF Margin for the quarter that ended in Jan. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	-22.76	/	1.075
	=	-2,117.21 %

Biovica International AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Biovica International AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB (OSTO:BIOVIC B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

9II:Germany

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

http://www.biovica.com

Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines